HEALTHCARE methods around the globe are grappling with the arrival of a brand new sort of weight-loss therapy: injections primarily based on the drugs semaglutide, which is branded as Wegovy or Ozempic.
The UK is among the many first international locations the place semaglutide appears set to be made obtainable for weight-loss therapy by a publicly funded well being system. Sadly, many medical doctors suppose England’s steering physique has made a misstep by recommending individuals be restricted to 2 years of use, despite the fact that the drug is supposed to be taken long-term. Well being methods in different international locations are additionally debating how to reply to this unprecedented scenario, …